W. S. Singleton - Concepedia

Author

W. S. Singleton

Southern Regional Research Center

Also Known As

W S SINGLETON, W. S. SINGLETON, W. S. Singleton, W. Sidney Singleton, W.S. SINGLETON, W.S. Singleton, Walter Singleton

Publications

4.9K

Citations

H-Index

Concepts

All Affiliations

Southern Regional Research Center Ionis Pharmaceuticals (United States)University of California San Diego Pfizer (United States)Université de Montréal

About

W. S. Singleton is an author at Southern Regional Research Center specializing in food chemistry, engineering, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	10	11	1.6K
2	Medicine	10	12	2.5K
3	Health Sciences	6	6	124
4	Natural Sciences	4	4	170
5	Education	1	1	10

W. S. Singleton

Publications

4.7K

Citations

H-Index

Page 1

	Year	Citations
Chromatographically homogeneous lecithin from egg phospholipids W. S. Singleton, M. S. Gray, M. L. Brown, Journal of the American Oil Chemists Society Lipid AnalysisOther CholineHomogeneous LecithinBiochemistryEngineering	1965	1.3K
Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia Daniel Gaudet, Veronica J. Alexander, Brenda F. Baker, New England Journal of Medicine	2015	515
Targeting APOC3 in the Familial Chylomicronemia Syndrome Daniel Gaudet, Diane Brisson, Karine Tremblay, New England Journal of Medicine GeneticsGenetic EpidemiologyPathologyHyperlipidemiaEpigenetics	2014	477
Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 study Sotirios Tsimikas, Nicholas J. Viney, Steven G. Hughes, The Lancet Lipid DisorderPharmacologyTherapeutic EfficacyHyperlipidemiaAntisense Therapy	2015	460
Antisense Oligonucleotide Inhibition of Apolipoprotein C-III Reduces Plasma Triglycerides in Rodents, Nonhuman Primates, and Humans Mark J. Graham, Richard Lee, Thomas A. Bell, Circulation Research	2013	364
Vupanorsen, an N-acetyl galactosamine-conjugated antisense drug to <i>ANGPTL3</i> mRNA, lowers triglycerides and atherogenic lipoproteins in patients with diabetes, hepatic steatosis, and hypertriglyceridaemia Daniel Gaudet, Ewa Karwatowska‐Prokopczuk, Seth J. Baum, European Heart Journal	2020	258
Transcranial ultrasound in clinical sonothrombolysis (TUCSON) trial Carlos A. Molina, Andrew D. Barreto, Georgios Tsivgoulis, Annals of Neurology	2009	226
Antisense-Mediated Lowering of Plasma Apolipoprotein C-III by Volanesorsen Improves Dyslipidemia and Insulin Sensitivity in Type 2 Diabetes Andrés Digenio, Richard L. Dunbar, Veronica J. Alexander, Diabetes Care	2016	165
Clinical pharmacokinetics of nifedipine gastrointestinal therapeutic system Menger Chung, Donald P. Reitberg, Michael Gaffney, The American Journal of Medicine Gastrointestinal PharmacologyMedicineGastroenterologyClinical PharmacologyPharmacotherapy	1987	132
Comparison of the Immediate Effects of Five β-Adrenoreceptor-Blocking Drugs with Different Ancillary Properties in Angina Pectoris Udho Thadani, Christopher Davidson, W. S. Singleton, New England Journal of Medicine	1979	99

Page 1